P3‐399: ASSOCIATION BETWEEN CORTICAL THINNING AND TAU PATHOLOGY IN PRECLINICAL AUTOSOMAL DOMINANT ALZHEIMER'S DISEASE
Yakeel T. Quiroz,Cinthya Aguero,Francisco Lopera,Daniel J. Norton,Daniel C. Aguirre-Acevedo,Kewei Chen,Ana Baena,Jennifer R. Gatchel,Edmarie Guzman-Velez,Enmanuelle Pardilla-Delgado,Arabiye Artola,Sergio Alvarez,Reisa A. Sperling,Eric M. Reiman,Keith A. Johnson
DOI: https://doi.org/10.1016/j.jalz.2018.06.1761
2018-01-01
Abstract:Research has suggested that cortical thinning in key brain regions can be used to identify individuals at high risk for Alzheimer's disease (AD). We previously reported that unimpaired individuals with autosomal dominant Alzheimer's disease have cortical thinning in parietal regions, several years before their anticipated clinical onset (Quiroz et al., 2013). Here we compared brain imaging measurements of cortical thickness, amyloid and tau pathology, and characterized associations with memory performance in mutation carriers and non-carriers from the Colombian Presenilin-1 (PSEN1) E280A kindred. We used structural MRI, PiB-PET, Flortaucipir (FTP)-PET, and memory testing (CERAD Word List Recall) for the assessment of 12 unimpaired mutation carriers (mean age= 37±3), approximately 7 years before the kindred's median age at mild cognitive impairment (MCI) onset, and 24 age-matched non-carrier family members. Automated brain mapping algorithms were used to compute mean cortical PiB DVRs, entorhinal cortex (EC) and inferior temporal (IT) flortaucipir SUVRs. Cortical thickness was measured in the signature of familial AD (Weston et al., 2016), which included 6 regions: entorhinal cortex, inferior parietal cortex, precuneus, superior parietal cortex, superior frontal cortex, and supra marginal gyrus. Spearman's correlations were used to characterize relationships among these brain imaging and memory measurements. Compared to non-carriers, unimpaired PSEN1 mutation carriers showed cortical thinning in the FAD signature (p=0.001). In the carrier group, cortical thinning in the mean signature summary measure was not associated with amyloid burden, but was associated with EC tau levels (r=-0.75; p-value= 0.02). EC and IT tau were associated with thinning in precuneus, superior frontal cortex, and superior parietal cortex (p<0.05). Further, worse memory performance was associated with a lower mean cortical thickness in the familial AD signature (r= 0.73; p-value: 0.005). This study provides preliminary information about the limited associations between amyloid burden and cortical thinning in preclinical autosomal dominant AD. Findings suggest that regional tau burden is associated with cortical thinning and memory decline in individuals at virtually certain risk for Alzheimer's disease, more than 5 years prior to symptom onset.